lobbying_filings_raw: 079035f4-0d1f-485f-b656-e097d6fdeccb
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json | registrant_state | registrant_country | registrant_house_id | client_state | client_ppb_state | client_country | client_ppb_country | client_general_description | client_government_entity | affiliated_org_count | client_entity_id | client_government_unit_id | client_match_method | client_match_confidence |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 079035f4-0d1f-485f-b656-e097d6fdeccb | Q3 | 31747 | POLICY DIRECTIONS INC. | 138922 | NATIONAL ASSN FOR BIOMEDICAL RESEARCH | 2011 | third_quarter | 2011-10-18T15:09:18.600000-04:00 | 20000.0 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/079035f4-0d1f-485f-b656-e097d6fdeccb/", "filing_uuid": "079035f4-0d1f-485f-b656-e097d6fdeccb", "filing_type": "Q3", "filing_type_display": "3rd Quarter - Report", "filing_year": 2011, "filing_period": "third_quarter", "filing_period_display": "3rd Quarter (July 1 - Sep 30)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/079035f4-0d1f-485f-b656-e097d6fdeccb/print/", "filing_document_content_type": "text/html", "income": "20000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "FRANKIE L. TRULL, PRESIDENT & CEO", "dt_posted": "2011-10-18T15:09:18.600000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "818 CONNECTICUT AVENUE, NW, #950", "registrant_address_2": null, "registrant_different_address": false, "registrant_city": "WASHINGTON, DC", "registrant_state": "DC", "registrant_zip": "20006", "registrant": {"id": 31747, "url": "https://lda.senate.gov/api/v1/registrants/31747/", "house_registrant_id": 32112, "name": "POLICY DIRECTIONS INC.", "description": "Government Relations", "address_1": "1100 Vermont Avenue, NW, Suite 1100", "address_2": null, "address_3": null, "address_4": null, "city": "Washington", "state": "DC", "state_display": "District of Columbia", "zip": "20005", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "FRANKIE L. TRULL", "contact_telephone": "", "dt_updated": "2022-04-06T16:06:15.150422-04:00"}, "client": {"id": 138922, "url": "https://lda.senate.gov/api/v1/clients/138922/", "client_id": 90, "name": "NATIONAL ASSN FOR BIOMEDICAL RESEARCH", "general_description": null, "client_government_entity": false, "client_self_select": null, "state": "DC", "state_display": "District of Columbia", "country": "US", "country_display": "United States of America", "ppb_state": null, "ppb_state_display": null, "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2007-07-30"}, "lobbying_activities": [{"general_issue_code": "ANI", "general_issue_code_display": "Animals", "description": "Animal Welfare Act Regulations & Policies.\nH.R. 403 - Battlefield Excellence through Superior Training Practices Act. \nH.R. 1513 and S. 810 - Great Ape Protection and Cost Savings Act of 2011.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 40454, "prefix": null, "prefix_display": null, "first_name": "FRANKIE", "nickname": null, "middle_name": "L", "last_name": "TRULL", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 23, "name": "Agriculture, Dept of (USDA)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 139, "name": "Natl Institutes of Health (NIH)"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} | DC | US | 32112 | DC | US | US | 0 | 0 | 34813 | normalized_name_state | 0.9 |